Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset

Nat Commun. 2025 May 18;16(1):4621. doi: 10.1038/s41467-025-59626-0.

Abstract

Autoimmune destruction of pancreatic β cells results in type 1 diabetes (T1D), with pancreatic immune infiltrate representing a key feature in this process. However, characterization of the immunological processes occurring in human pancreatic lymphatic tissues is lacking. Here, we conduct a comprehensive study of immune cells from pancreatic, mesenteric, and splenic lymphatic tissues of non-diabetic control (ND), β cell autoantibody-positive non-diabetic (AAb+), and T1D donors using flow cytometry and CITEseq. Compared to ND pancreas-draining lymph nodes (pLN), AAb+ and T1D donor pLNs display decreased CD4+ Treg and increased stem-like CD8+ T cell signatures, while only T1D donor pLNs exhibit naive T cell and NK cell differentiation. Mesenteric LNs have modulations only in CD4+ Tregs and naive cells, while splenocytes lack these perturbations. Further, T cell expression of activation markers and IL7 receptor correlate with T1D genetic risk. These results demonstrate tissue-restricted immune changes occur before and after T1D onset.

MeSH terms

  • Adolescent
  • Adult
  • Autoantibodies / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Diabetes Mellitus, Type 1* / genetics
  • Diabetes Mellitus, Type 1* / immunology
  • Diabetes Mellitus, Type 1* / pathology
  • Female
  • Humans
  • Insulin-Secreting Cells / immunology
  • Killer Cells, Natural / immunology
  • Lymph Nodes / immunology
  • Lymphoid Tissue* / immunology
  • Male
  • Middle Aged
  • Pancreas* / immunology
  • Pancreas* / pathology
  • Spleen / immunology
  • T-Lymphocytes, Regulatory / immunology
  • Young Adult

Substances

  • Autoantibodies